Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 24|pp. 15025–15049
The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis
Back to articleFigure 1(1 of 4)
100%
Figure 1
Figure 1.Overall survival of NSCLC patients treated with ICIs based on age group in the cBio database. HR, hazard ratio.